JPM24: Roche says rebound in hematology sparked by potential of newly approved Lunsumio, Columvi
JPM24: Roche says rebound in hematology sparked by potential of newly approved Lunsumio, Columvi kdunleavy Tue, 01/09/2024 - 15:05
JPM24: Roche says rebound in hematology sparked by potential of newly approved Lunsumio, Columvi kdunleavy Tue, 01/09/2024 - 15:05
Astellas' gastric cancer candidate rejected by FDA because of manufacturing issues kdunleavy Tue, 01/09/2024 - 09:18
JPM24: Pfizer CEO promises 'year of execution' after recent struggles, Seagen buyout esagonowsky Tue, 01/09/2024 - 09:17
JPM24: Merck expects $20B+ in new cancer sales thanks to Daiichi ADC deal, Moderna vaccine aliu Tue, 01/09/2024 - 01:26
JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach zbecker Mon, 01/08/2024 - 18:25